Sign in
Not yet taking people in United StatesNo phase

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Key facts

Who runs it
University of Florida
Where
Gainesville, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
1,296 people, planned
Starts
15 Sept 2027
Expected to end
15 Sept 2028
Type of study
Interventional, 5 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Protect Me 4 Application + External Quality Improvement Support
  • Protect Me 4 Application Alone
Record updated
14 September 2026

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Must be parent of an adolescent aged 11-12 years old
  • Providers working with age appropriate for study adolescents at the intervention clinics
  • Adolescents/Parents/Providers willing to consent to participation
  • Adolescents/Parents that can read and speak English

Who cannot take part

  • Adolescents out of the age range for participation
  • Adolescents/Parents/Providers unwilling to consent to participation
  • Adolescents/Parents that can NOT read and speak English

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Where in United States

  • University of FloridaGainesville, United StatesContact: Stephanie Staras, PhDNot yet recruiting

About the trial

What the trial wants to find out

Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates remain low. The study team has developed an electronic application (app), Protect Me 4, to help parents and providers assess and have more productive conversations about needed vaccines.

Read full original descriptionShow less

The specific aims of this study are to: (1) evaluate the feasibility of implementing Protect Me 4, and (2) estimate preliminary efficacy of Protect Me 4 to increase HPV vaccine initiation (receipt of first dose).

The 5 groups in the trial

  • ParentsExisting treatment, for comparison

    Parents of 11-12 year old children who visit participating interventional clinics during study period.

    Treatment: Protect Me 4 Application + External Quality Improvement Support and Protect Me 4 Application Alone

  • Health Care ProviderExisting treatment, for comparison

    Health care providers and clinic staff for 11-12 year old patients at 4 participating pediatric clinics.

    Treatment: Protect Me 4 Application + External Quality Improvement Support and Protect Me 4 Application Alone

  • Adolescents at Intervention clinicsNo study treatment, for comparison

    Adolescents between 11-12 years of age. Adolescent vaccination data is used in the study, adolescents will assent to participate. The parents, however, use the HIT system.

  • Adolescents at Control ClinicNo study treatment, for comparison

    Parents of 11-12 year old children who visit participating control clinics during study period.

  • Health Care Provider at Control ClinicNo study treatment, for comparison

    Health care providers and clinic staff for 11-12 year old patients at 3 participating pediatric control clinics.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT03429413, who can take part
Record updated
14 September 2026